Changeflow GovPing Healthcare & Life Sciences Intraosseous Antibiotic Prophylaxis in Hip Repl...
Routine Notice Added Final

Intraosseous Antibiotic Prophylaxis in Hip Replacement, Somerset, NJ

Favicon for clinicaltrials.gov ClinicalTrials.gov - Phase 4 Trials
Detected
Email

Summary

A Phase 4 clinical trial (NCT07549542) has been registered on ClinicalTrials.gov investigating intraosseous antibiotic prophylaxis in hip replacement surgery. The trial is being conducted in Somerset, New Jersey. This registry entry provides information about the study's purpose and location but contains limited detail about the study protocol, enrollment criteria, or outcomes.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 10 changes logged to date.

What changed

A new clinical trial registration has been posted to ClinicalTrials.gov for a Phase 4 study on intraosseous antibiotic prophylaxis in hip replacement surgery. The trial is listed as being conducted in Somerset, New Jersey. Trial registrations on ClinicalTrials.gov are informational records that describe the study's purpose, design, and location but do not themselves impose compliance obligations on sponsors, investigators, or healthcare providers.

Healthcare providers and clinical investigators conducting or monitoring orthopedic surgery trials should note this trial as part of the broader landscape of infection-prevention studies in joint replacement. The trial ID NCT07549542 can be used to monitor for future protocol postings or results submissions on ClinicalTrials.gov.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 4 Trials

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!